Equity Capital: 14.24 Cr FV: 10.00
| Period | MF Net Purchase / (sold) | FII Net |
|---|---|---|
| LAST 1M | 10,846.35 | -17,022.91 |
| LAST 3M | 25,915.29 | -5,903.92 |
| LAST 6M | 50,214.07 | 67,090.14 |
| LAST 12M | 182,243.81 | -105,158.90 |
| Date | Action Type | Ratio |
|---|---|---|
| Nov 28, 2022 | Dividend | .5 |
| Jul 20, 2022 | Dividend | 1 |
Established in 1982 as a partnership firm, Pharma Offset became a public limited company in Sep.`94. It was promoted by Rashmikant C Doshi and Uday M Raval. The company is engaged in manufacturing, processing, printing and packaging products. The company`s product profile consists of cartons, pharmaceutical sales promotion literature, primary packaging materials, etc. The company undertook an expansion-cum-modernisation programme in 1994-95. It came out with a public issue in Jan.`95 to part-finance the project. Pharma Offset supplies its products to reputed pharmaceutical companies like Lyka Labs, Dolphin Laboratories and to multi-nationals like Parke-Davis, Sandoz, Merind, Fulford (India), etc. The company has entered into a firm tie-up with Lyka Labs and Dolphin Laboratories for an offtake of upto 60% of the expanded capacity. In 1998-99, the company commenced an additional activity of trading in chemicals and bulk drugs. During the year 1999-2000, the company has changed its name to Pharma Com (India) Ltd.
Plot No A-357 Road No 26, Wagle Industrial Estate MIDC, Thane (West), Maharashtra, 400604
| Tel | : | 91-22-25833205 |
| : | csscandent:gmail.com | |
| Website | : | http://www.scandent.in |
Pharma Offset Limited
| AGM Date (Month) | : | Sep |
| Face Value Equity Shares | : | 10 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 516110 |
| NSE Code | : | |
| Book Closure Date (Month) | : | Sep |
| BSE Group | : | X |
| ISIN | : | INE146N01016 |
ICICIdirect Family Care Hospitals Ltd FAQ 
Stock Screener (i-Lens)
